Breakthrough <scp>SARS</scp> – <scp>CoV</scp> ‐2 Infections in Patients With <scp>Immune‐Mediated</scp> Disease Undergoing B Cell–Depleting Therapy: A Retrospective Cohort Analysis-Reference-Cited by-同舟云学术

Breakthrough SARS – CoV ‐2 Infections in Patients With Immune‐Mediated Disease Undergoing B Cell–Depleting Therapy: A Retrospective Cohort Analysis

Published:2022-10-31 Issue:12 Volume:74 Page:1906-1915
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Calabrese Cassandra M.¹,Kirchner Elizabeth¹,Husni Elaine M.¹^ORCID,Moss Brandon P.²,Fernandez Anthony P.³^ORCID,Jin Yuxuan⁴,Calabrese Leonard H.¹^ORCID

Affiliation:

1. Department of Rheumatic and Immunologic Diseases Cleveland Clinic Cleveland Ohio

2. Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Cleveland Ohio

3. Department of Dermatology Cleveland Clinic Cleveland Ohio

4. Quantitative Health Sciences Cleveland Clinic Cleveland Ohio

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.42287

Reference31 articles.

1. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

2. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases

3. Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2

4. COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review

5. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination;Vaccines;2024-08-19

2. Review of the Longitudinal Management of Autoimmune Encephalitis, Potential Biomarkers, and Novel Therapeutics;Neurology Clinical Practice;2024-08

3. A Descriptive, Retrospective Analysis of COVID-19 Passive Antibody Therapy and Its Effects on Morbidity and Mortality in Patients Receiving B-Cell-Depleting Therapies;Diseases;2024-02-06

4. The Future of COVID-19 for Patients With Immune-Mediated Inflammatory Diseases: Who Is at Risk?;The Journal of Rheumatology;2024-01-15

5. Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study;Annals of the Rheumatic Diseases;2024-01-10